Helfie AI redefines human health by pairing everyone with their own health AI—checking key conditions, delivering intelligent insights, and enabling persistent monitoring, all via mobile for cents. It’s the world’s first preventative health and early detection system, accessible to all 8 billion+ humans. Pulse 2.0 interviewed Helfie AI founder and director George Tomeski to learn more about the company.
George Tomeski’s Background
What is George Tomeski’s background? Tomeski said:
“Looking back isn’t something I do – or like to. I believe relying too much on what we did yesterday impairs what we can do today and tomorrow. To start new and fresh every time requires a certain intellectual and creative openness, even a necessary naivety when tackling something big.”
“My career has been a series of diverse roles and ventures. I started in publishing during college, persuading decision-makers to take a chance on launching new titles—we didn’t have a detailed plan, just an instinct for where the industry was heading. From there, I co-founded ad agencies, scaled them into multinationals, and then dove headfirst into the dynamic world of tech. I’ve always been drawn to what’s next, even if it meant being in over my head.”
Formation Of Helfie
How did the idea for the company come together? Tomeski shared:
“It began in the most ordinary way—no lightbulb moment or divine inspiration, just a routine visit to the doctor after my family nudged me, realizing it had been 12 years since my last check-up. Health time flies even faster than regular time. My wife had been urging me to get checked, especially for skin cancer, which is common advice in Australia. It struck me as absurd that despite knowing the risks, many people, including myself, skip preventive health checks. Seven out of 10 deaths are caused by conditions that could have been prevented if only they’d been caught earlier.”
“So, we set out to create something so convenient and low-cost that engaging in preventive health would be unavoidable. We knew it had to cover all the major preventable conditions—skin cancers, respiratory issues, cardiovascular diseases and more—and that’s how Helfie AI began.”
Job As CEO
What is your job as CEO? Tomeski noted:
“As the Founder and CEO, I’m not a healthcare expert, data scientist, nor engineer. My role is to attract top talent, provide them with meaningful, rewarding opportunities, keep everyone aligned to our vision of preventative health for all eight billion humans, and occasionally step in to help solve the tough problems. I steer the ship, making space for our talented team to do their best work, but ready to jump into the fray when needed. I ensure they have what they need, the freedom to push boundaries, and the resilience to keep going. It’s a privilege to be part of this team, the problem they’re tacking and changes we’re driving in healthcare for people.”
Favorited Memory Working for the Company
What is your favorite memory working for the company? Tomeski reflected:
‘Thank you for this question—it made me think, reflect.”
“My fondest memories are those breakthrough moments, when the team comes to me excited about a major step forward, bringing us closer to our goals.”
“Personally, I love imagining the possibilities if we succeed, the doors we could open. New companies are visions of the future with perspectives on how the world could be. It’s those quiet, chaotic moments—staring at a whiteboard full of scribbles, or at a computer at 3 AM, wrestling with half-formed ideas until something clicks. Building a company is like alchemy: you throw in bits and pieces, hoping it doesn’t explode but knowing it’s the only way to create the magic that makes great products, teams, and companies.”
“And then there are the people—meeting someone who makes you think, ‘Imagine solving this with them.’ Part of my job is to turn ambiguity into clarity, not through magic, but through persistence and refining our vision until others can see it too. My favourite memories are when that vision becomes tangible for everyone on the team. And then there’s my daughter, who once read through one of my presentations and said it needed ‘more pizzazz.’ So don’t be surprised if you see a unicorn or two in a deck.”
Core Products And Features
What are the company’s core products and features? Tomeski explained:
“Before diving into specifics, let’s zoom out. We’re tackling two giants in healthcare—access and data. We’re redefining what it means to stay healthy, to live longer, and to ensure that health isn’t out of reach or dependent on luck, and that data isn’t someone else’s commodity, rather it’s working actively for your health; your body, your story, told back to you with insights that matter.”
“Access: We’re enabling everyone to engage in preventive health by catching problems before they become crises. Imagine a personal health AI on your phone that is able to check over 20 conditions—coughing to assess respiratory health, scanning your face for vital signs, snapping a photo for a skin cancer check, or snapping a pic of your poop for gut issues. It’s easy, instant, and costs mere cents per check. This AI remembers you, has a memory of your health patterns, and allows you to add any heath information you want—all while ensuring its response and insights are specifically for you.”
“Data: We’re putting health data back in the hands of the people. This isn’t about building another walled garden; it’s about giving everyone control of their health narrative. In an AI-driven future, whoever controls your health data benefits most—and that should be you. To ensure this, we’re creating a public digital infrastructure: the Decentralized Human Architecture Protocol.”
Challenges Faced
What challenges have Tomeski and the team face in building the company? Tomeski acknowledged:
“Challenges are the currency we trade in. Every step forward involves navigating obstacles, large and small. We’re here because the world wasn’t built for what we’re trying to achieve—if it were easy, it would already exist.”
“For us, each challenge demands a mix of brute force and finesse. Technical hurdles? We face them daily. While I’d love to say we simply wrestle them into submission, the truth is more complex. We adapt, adjusting our approach to align with our ambitions of universal access and data sovereignty. Each challenge becomes fuel for progress.”
Evolution of the Company’s Technology
How has the company’s technology evolved? Tomeski pointed out:
“Our tech has evolved profoundly and will keep evolving. We started with simple image models, moved to multiple LLMs for health checks, and integrated larger LLMs for orchestrating and synthesizing data. Now, we’re moving from these AI structures to newer, smarter architectures—swarm models, distributed ledgers, public protocols.”
“What began as a kernel of an idea—easy, instant health access—has grown and morphed as we dismantle the barriers to health access for eight billion people. It’s about creating new infrastructure with health outcomes embedded at a protocol level.”
Significant Milestones
What have been some of the company’s most significant milestones? Tomeski cited:
“Our milestones aren’t just about product capabilities or funding rounds; they’re moments proving that change is possible. Each time we show our vision isn’t a pipe dream but a blueprint for something better, it’s a milestone. And they’re moments when we attract great people, drawn by the strength of our mission and the tools we’re building to achieve it.”
Customer Success Stories
When asking Tomeski about customer success stories, he highlighted:
“We’re in Beta testing now for Helfie AI, but already receiving incredible feedback. Success isn’t just metrics or KPIs—it’s lives touched, problems intercepted before escalation, and people feeling empowered to navigate healthcare. The stories that will matter most are the ones that showcase real lives changed.”
Revenue
When asking Tomeski about the company’s revenue details, he revealed:
“We’re early-stage and still building. We have some revenue from B2B customers, but the direct-to-consumer application is set to launch later this year.”
Total Addressable Market (TAM)
What total addressable market is the company pursuing? Tomeski assessed:
“At its core, it’s simple: anyone who wants control over their health—eight billion people, with 6.5 billion already carrying a device in their pocket that could be their gateway. We’re not just building for today; we’re building a data protocol for humanity’s future engagement with health.”
“Helfie is targeting conditions responsible for the most preventable deaths: respiratory issues, cardiovascular disease, and more. The market for these conditions is vast, and conditions like STIs alone affect over one million people daily. If we can provide early detection for these conditions, we may shift the number that see’s seven out of 10 humans succumb to a preventable condition.”
Differentiators
When asking the company about the company’s differentiators, he affirmed:
“Our strength lies in the combination of our broad product scope, audacious strategy, and relentless ambition. We’re not here to patch up the current health system; we’re creating something entirely new for preventative health, early detection and predictive prevention. To achieve this scale, we need a new data model that protects and advances human health in an AI age.”
Future Goals
What are some of the company’s future goals? Tomeski emphasized:
“Short term, we’re launching our direct-to-consumer product to pave the way for preventative health access for all eight billion people, aiming to become the world’s leading consumer health brand. Our view is that AI will bring a new age in digital relationships, one where people benefit from trusted, personalized algorithms aligned with their well-being. Bridging the trust gap is key, and to do this, we’re re-architecting—not tweaking—the system.”
“Long term, our goal is to establish a public framework that protects human agency and life in an AI-powered world.”
Other Topics
Any other topics to discuss? Tomeski concluded:
“The conversation no one’s having—perhaps because they’re resigned to ‘it is what it is’—is about the health system’s limitations. We’ve poured $140 trillion into healthcare over the past 20 years, yet people still die from the same conditions we faced decades ago. Despite unprecedented innovation, life expectancy is declining in the wealthiest nations, alongside access.”
“This isn’t finger-pointing; it’s recognizing that the healthcare sector, the world’s most profitable industry, can no longer deliver the outcomes communities deserve. We need an entirely new economic and data architecture for human health. That’s the conversation we need to have, and while the industry has no incentive to start it, we’re here to get the ball rolling.”
